SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-045754
Filing Date
2023-12-21
Accepted
2023-12-21 17:14:09
Documents
7
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 31134
2 ex10-1.htm EX-10.1 130122
3 ex10-2.htm EX-10.2 133370
4 ex10-3.htm EX-10.3 150487
5 ex10-4.htm EX-10.4 245891
6 ex10-5.htm EX-10.5 15916
7 ex99-1.htm EX-99.1 11015
  Complete submission text file 0001493152-23-045754.txt   719209
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41231 | Film No.: 231506157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)